INVESTIGATING THE EFFICACY AND SAFETY OF SGLT2 INHIBITORS FOR CARDIOVASCULAR PROTECTION IN PATIENTS WITH OBESITY AND TYPE 2 DIABETES. RMSR. 2025;3(4):307-312. Accessed April 30, 2025. http://www.thermsr.com/index.php/Journal/article/view/929